Cargando…
Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) have completely changed the treatment of cancer, and they also can cause multiple organ immune-related adverse reactions (irAEs). Among them, rheumatic irAE is less common, mainly including inflammatory arthritis, rheumatic myalgia/giant cell arteritis, inflammato...
Autores principales: | Xiao, Yan, Zeng, Lin, Shen, Qinglin, Zhou, Zhiyong, Mao, Zhifang, Wang, Qin, Zhang, Xiquan, Li, Yingliang, Yao, Weirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424376/ https://www.ncbi.nlm.nih.gov/pubmed/32832568 http://dx.doi.org/10.1155/2020/2640273 |
Ejemplares similares
-
Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors
por: Zhong, Hui, et al.
Publicado: (2020) -
Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019) -
Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
por: Zeng, Li, et al.
Publicado: (2023) -
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
por: Bobircă, Anca, et al.
Publicado: (2021) -
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
por: Dang, Quang Minh, et al.
Publicado: (2023)